We present a case of successful peritoneal ultrafiltration (pUF) treatment in a 60 year-old patient diagnosed with diuretic-resistantcongestive heart failure fulfilling the criteria for type 2 cardio-renal syndrome. Six months of pUF treatment with onedaily dialysis exchange with icodextrin as an osmotic agent resulted in better functional status (from IV to II/III NYHA class),quality of life and improvement of haemodynamic parameters measured by impedance cardiography. During the follow-up(six months), pUF was well tolerated by the patient and he did not require hospitalisation for decompensated heart failure
In patients with heart failure fluid overload is clinically evident as systemic and/or pulmonary con...
Congestive heart failure unresponsive to maximal drug treatment has been known to benefit from UF. W...
Background: Peritoneal ultrafiltration needs consideration as a therapeutic option for improvement i...
Diuretic-resistant congestive heart failure treated successfully with peritoneal ultrafiltration Sku...
INTRODUCTION: Acutely decompensated heart failure (HF) in patients with diuretic resistance is often...
Congestive heart failure (CHF) refractory to pharmacological therapy is a growing medical problem. R...
The aim of the Best Practice guidelines on peritoneal ultrafiltration (UF) in patients with treatmen...
The aim of the Best Practice guidelines on peritoneal ultrafiltration (UF) in patients with treatmen...
IntroductionDespite continuous improvement in the treatment, heart failure (HF) is a growing health ...
Diuretics are the mainstay of treatment of refractory heart failure. There is a high incidence of dy...
Cardiorenal syndrome (CRS) is a general term that can reflect different clinical conditions in which...
Heart failure is a significant health problem worldwide. Despite all the new therapies available now...
Diuretic therapy has been the cornerstone of the medical treatment in patients with heart failure fo...
Peritoneal ultrafiltration (PuF) has been employed for severe heart failure (HF), but evidence for i...
Artificial subtraction of fluids and solutes was evaluated in the course of acute and chronic heart ...
In patients with heart failure fluid overload is clinically evident as systemic and/or pulmonary con...
Congestive heart failure unresponsive to maximal drug treatment has been known to benefit from UF. W...
Background: Peritoneal ultrafiltration needs consideration as a therapeutic option for improvement i...
Diuretic-resistant congestive heart failure treated successfully with peritoneal ultrafiltration Sku...
INTRODUCTION: Acutely decompensated heart failure (HF) in patients with diuretic resistance is often...
Congestive heart failure (CHF) refractory to pharmacological therapy is a growing medical problem. R...
The aim of the Best Practice guidelines on peritoneal ultrafiltration (UF) in patients with treatmen...
The aim of the Best Practice guidelines on peritoneal ultrafiltration (UF) in patients with treatmen...
IntroductionDespite continuous improvement in the treatment, heart failure (HF) is a growing health ...
Diuretics are the mainstay of treatment of refractory heart failure. There is a high incidence of dy...
Cardiorenal syndrome (CRS) is a general term that can reflect different clinical conditions in which...
Heart failure is a significant health problem worldwide. Despite all the new therapies available now...
Diuretic therapy has been the cornerstone of the medical treatment in patients with heart failure fo...
Peritoneal ultrafiltration (PuF) has been employed for severe heart failure (HF), but evidence for i...
Artificial subtraction of fluids and solutes was evaluated in the course of acute and chronic heart ...
In patients with heart failure fluid overload is clinically evident as systemic and/or pulmonary con...
Congestive heart failure unresponsive to maximal drug treatment has been known to benefit from UF. W...
Background: Peritoneal ultrafiltration needs consideration as a therapeutic option for improvement i...